Discover 951 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 951
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
for
Oropharyngeal Cancer
Location: Portland OR, Vancouver, Duarte CA, Corona CA, Winnipeg,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT05451004
Phase3, Recruiting
Endolumenal Partial Myotomy for Esophageal Motility Disorders
for
Esophageal Motility Disorders
Location: Portland OR
Sponsor: The Oregon Clinic
Sex: All
Age: 18 - 70+
Code: NCT01302301
Phase2, Recruiting
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
for
Small Cell Lung Cancer (SCLC),
Location: Portland OR, Seattle WA, Duarte CA, Los Angeles CA,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05652686
Phase1, Phase2, Recruiting
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
for
Gastric Cancer, Gastroesophageal Junction Cancer
Location: Portland OR, Dallas TX, Skokie IL, Ann Arbor MI,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06731478
Phase3, Recruiting
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Location: Portland OR, San Francisco CA, Palo Alto CA, Irvine CA,
Sponsor: University of Miami
Sex: All
Age: 18+
Code: NCT03489278
Recruiting
GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma
for
Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma
Location: Portland OR
Sponsor: Providence Health & Services
Sex: All
Age: 18+
Code: NCT05913388
Phase2, Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
for
Breast Cancer, Solid Tumors, Adult
Location: Portland OR, San Francisco CA, West Valley City UT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05768139
Phase1, Phase2, Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant
Location: Portland OR, Seattle WA, Vancouver, San Francisco CA,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase3, Recruiting
Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors
for
Solid Tumor, Cancer Metastatic
Location: Portland OR, Woburn MA
Sponsor: CanWell Pharma Inc.
Sex: All
Age: 18 - 70+
Code: NCT04987112
Phase1, Recruiting
The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study
for
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Location: Portland OR, Minneapolis MN, Green Bay WI, Hinsdale IL,
Sponsor: Luminate Medical, Inc.
Sex: All
Age: 18+
Code: NCT07142304
Recruiting
First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors
for
Select Advanced Solid Tumors
Location: Portland OR, Ann Arbor MI, Philadelphia PA, Miami FL
Sponsor: CDR-Life AG
Sex: All
Age: 18+
Code: NCT06402201
Phase1, Recruiting
A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies
for
Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer,
Location: Portland OR, Scottsdale AZ, Irving TX, San Antonio TX,
Sponsor: Incendia Therapeutics
Sex: All
Age: 18+
Code: NCT05753722
Phase1, Recruiting
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: Portland OR, Santa Monica CA, Irving TX, San Antonio TX,